News

PMCPA News

Press releases appear below, filter by date.

Vacancy Manager, PMCPA (12 Month FTC)

Vacancy Manager, PMCPA (12 Month FTC)

Press release: 18 October 2022
PMCPA Advice - The provision of Adverse Event Reporting statements in relation to digital materials

PMCPA Advice - The provision of Adverse Event Reporting statements in relation to digital materials

Press release: 18 November 2022
Novo Nordisk, Daiichi-Sankyo, Lundbeck, AstraZeneca, UCB and Biogen named in advertisements for breaches of the ABPI Code

Novo Nordisk, Daiichi-Sankyo, Lundbeck, AstraZeneca, UCB and Biogen named in advertisements for breaches of the ABPI Code

Press release: 12 December 2022
New Senior Appointments at the PMCPA

New Senior Appointments at the PMCPA

Press release: 20 December 2022
Making a complaint form outage/issue

Making a complaint form outage/issue

Press release: 12 January 2023
PMCPA launches new social media guidance for pharmaceutical companies

PMCPA launches new social media guidance for pharmaceutical companies 

Press release: 26 January 2023
PMCPA Social Media Guidance 2023 - Recordings and a copy of the slides are now available

PMCPA Social Media Guidance 2023 - Recordings of the webinar and a copy of the slides

Press release: 27 February 2023
New PMCPA Managers - Helen Darracott and Ciara O’Brien

New PMCPA Managers - Helen Darracott and Ciara O’Brien

Press release: 10 March 2023
Vacancies for independent members of the Code of Practice Appeal Board

Vacancies for independent members of the Code of Practice Appeal Board

Press release: 19 April 2023
Changes to PMCPA Case Reports

Changes to PMCPA Case Reports

Press release: 21 April 2023
Q&As from the social media webinar ran by the PMCPA earlier this year are now published

Q&As from the social media webinar ran by the PMCPA earlier this year are now published

Press release: 01 June 2023
Leo Pharma, AstraZeneca and Daiichi Sankyo have been named in advertisements for bringing discredit upon, and reducing confidence in, the pharmaceutical industry.

Leo Pharma, AstraZeneca and Daiichi Sankyo have been named in advertisements for bringing discredit upon, and reducing confidence in, the pharmaceutical industry.

Press release: 16 June 2023
About 156 result(s)